Kategorien
- Kommunikation und Marketing
- Wissenschaft
- Interviews
- Jobs, Karriere und Ausbildung
- Krebsinformationsdienst
- Lernen
474 views
0 Kommentare
0 likes
0 favorites
Session 7
Michael Cox: Developing Inhibitors Against Rare Oncogenic Kinases
Mark Cowley: Zero Childhood Cancer: A comprehensive precision medicine platform for children with high-risk cancer
Pratiti (Mimi) Bandopadhayay: Cell-cycle and neuronal differentiation programs mediate response to BET-bromodomain inhibitors in MYC-driven medulloblastoma
Frank Westermann: Novel metabolic dependencies of MYCN-driven childhood neuroblastomas: Cyst(e)ine as a promising therapeutic target
Holger Lode: Passive GD2 directed immunotherapy upregulate the PD1/PD-L1 immune checkpoint in neuroblastoma: a rationale for combination therapy
0 Kommentare
Es gibt noch keine Kommentare. Fügen Sie einen Kommentar hinzu.